Targeted drug delivery of Rifampicin to the lungs: formulation, characterization, and stability studies of preformed aerosolized liposome and in situ formed aerosolized liposome

Mycobacterium tuberculosis: here today, and here tomorrow

Russell, D. G. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085034 · Cited by 781 · see citing works

Pharmacokinetic Interactions with Rifampicin

Niemi, M., Backman, J. T., Fromm, M. F., Neuvonen, P. J., & Kivist, K. T. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342090-00003 · Cited by 766 · see citing works

Targeted and Controlled Drug Delivery: Novel Carrier Systems

Florence, A. J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00356-9 · Cited by 283 · see citing works

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

Vyas, S. P., Kannan, M., Jain, S., Mishra, V. K., & Singh, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.017 · Cited by 262 · see citing works

Principles of Metered-Dose Inhaler Design

Newman, S. P. (2005) · Respiratory Care · doi:10.4187/respcare.05501177 · Cited by 247 · see citing works

Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.

Fidler, I. J., Raz, A., Fogler, W. E., et al. (1980) · PubMed · Cited by 182 · see citing works

Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice

Deol, P., & Khuller, G. K. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(96)00088-8 · Cited by 160 · see citing works

Liposomes for drug delivery to the lungs by nebulization

Zaru, M., Mourtas, S., Klepetsanis, P. G., Fadda, A. M., & Antimisiaris, S. G. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.04.005 · Cited by 131 · see citing works

Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice

Deol, P., Khuller, G. K., & Joshi, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1211 · Cited by 128 · see citing works

Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin

TASDUQ, S., Peerzada, K. J., KOUL, S., et al. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.01.005 · Cited by 127 · see citing works

Exposure-response relationships and drug interactions of sirolimus

Zimmerman, J. J. (2004) · The AAPS Journal · doi:10.1208/aapsj060428 · Cited by 123 · see citing works

The stability of liposomes to nebulisation

Taylor, K. M. G., Taylor, G., Kellaway, I. W., et al. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90287-e · Cited by 119 · see citing works

The twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers

Hallworth, G. W., & Westmoreland, D. G. (1987) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1987.tb03142.x · Cited by 117 · see citing works

99m-Technetium as a marker of liposomal deposition and clearance in the human lung

FARR, S., Kellaway, I. W., Parry-Jones, D. R., et al. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90239-x · Cited by 109 · see citing works

Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation

Changsan, N., Chan, H., Separovic, F., & Srichana, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21441 · Cited by 108 · see citing works

Optimization of Aerosol Deposition by Pressure Support in Children with Cystic Fibrosis

Fauroux, B., Itti, E., Pigeot, J., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003069 · Cited by 104 · see citing works

Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes

Labana, S., Pandey, R., Sharma, S., & Khuller, G. K. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00175-9 · Cited by 101 · see citing works

Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages

Vyas, S. P., QURAISHI, S., Gupta, S., & Jaganathan, K. S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.003 · Cited by 100 · see citing works

Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy

Gürsoy, A., Kut, E., & Özkırımlı, S. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.033 · Cited by 83 · see citing works

Stability of rifampicin in dissolution medium in presence of isoniazid

Shishoo, C. J., Shah, S. A., Rathod, I. S., et al. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00286-0 · Cited by 82 · see citing works

Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies

Mansilha, C., Gameiro, P., PRIETO, M. J. E., & de Castro, B. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00528-7 · Cited by 66 · see citing works

In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates.

Feddah, M. R., Brown, K. F., Gipps, E. M., et al. (2001) · PubMed · Cited by 62 · see citing works

Pharmacokinetic Interaction between Rifampin and the Combination of Indinavir and Low‐Dose Ritonavir in HIV‐Infected Patients

Justesen, U. S., Andersen, Å. B., Klitgaard, N. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380794 · Cited by 62 · see citing works

Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants

Butz, N., Porté, C., Courrier, H. M., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00086-8 · Cited by 53 · see citing works

Special Problems in Aerosol Delivery: Artificial Airways

Dhand, R. (2000) · Respiratory Care · doi:10.1177/002013240004500607 · Cited by 53 · see citing works

Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice

Saito, H., & Tomioka, H. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.429 · Cited by 50 · see citing works

Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery

Bhavane, R. C., Karathanasis, E., & Annapragada, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00359-6 · Cited by 46 · see citing works

Approaches and Challenges to Use Freon Propellant Replacements

Leach, C. (1995) · Aerosol Science and Technology · doi:10.1080/02786829408959750 · Cited by 44 · see citing works

A novel dosing method for drug administration to the airways of the isolated perfused rat lung

Byron, P. R., & Niven, R. W. (1988) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600770810 · Cited by 43 · see citing works

Assessing the potential of aerosol-generated liposomes from pressurised pack formulations

Farr, S. J., Kellaway, I. W., & Carman-Meakin, B. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90003-4 · Cited by 37 · see citing works

Pulmonary delivery of amikacin liposomes and acute liposome toxicity in the sheep

Schreier, H., McNicol, K. J., Ausborn, M., et al. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90242-t · Cited by 30 · see citing works

A method of resuspending small vesicles separated from suspension by protamine aggregation and centrifugation

Gunter, K. K., Gunter, T. E., Jarkowski, A., et al. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90326-8 · Cited by 28 · see citing works

The pharmacokinetics of inhaled hydrofluoroalkane formulations☆☆☆

Borgström, L. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70040-0 · Cited by 27 · see citing works

Experimental pulmonary delivery of cyclosporin A by liposome aerosol

Waldrep, J. C., Arppe, J., Jansa, K., & Vidgren, M. T. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00322-0 · Cited by 25 · see citing works

In Vitro Method of Comparing Clouds Produced from Inhalation Aerosols for Efficiency in Penetration of Airways

Kirk, W. F. (1972) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600610227 · Cited by 25 · see citing works

Molecular and physicochemical aspects of the interactions of the tuberculostatics ofloxacin and rifampicin with liposomal bilayers: a 31P-NMR and DSC study

Bermudez, M. H., Martinez, E., Mora, M., Sagristá, M. L., & de Madariaga, M. A. (1999) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(99)00131-4 · Cited by 25 · see citing works

Amikacin liposomes: characterization, aerosolization, and in vitro activity against Mycobacterium avium-intracellulare in alveolar macrophages

Wichert, B., Gonzalez‐Rothi, R. J., Straub, L., et al. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90375-c · Cited by 25 · see citing works

The potential use of raman mapping to investigate in vitro deposition of combination pressurized metered-dose inhalers

Steele, D. F., Young, P. M., Price, R., et al. (2004) · The AAPS Journal · doi:10.1208/aapsj060432 · Cited by 22 · see citing works

High dose cyclosporin A and budesonide-liposome aerosols.

Waldrep, J. C., Arppe, J., Jansa, K., & Knight, V. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)04912-0 · Cited by 21 · see citing works

Stabilization of aerosolized IFN-γ by liposomes

Kanaoka, E., Nagata, S., & Hirano, K. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00218-5 · Cited by 20 · see citing works

Carrageenans can regulate the pulmonary absorption of antiasthmatic drugs and their retention in the rat lung tissues without any membrane damage

Yamada, K., Kamada, N., Odomi, M., et al. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.008 · Cited by 20 · see citing works

Comparison of solute partitioning and efflux in liposomes formed by a conventional and an aerosolised method

FARR, S., Kellaway, I. W., & Carman-Meakin, B. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90072-0 · Cited by 20 · see citing works

Evaluation of a Liposome System for the Delivery of Desferrioxamine to Lungs in Rats

Tabak, A., Hoffer, E., & Taitelman, U. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03731.x · Cited by 15 · see citing works

Bacteriostatic activity and decomposition products of rifampicin in aqueous solution and liposomal composition

Sorokoumova, G. M., Vostrikov, V. V., Селищева, А. А., et al. (2008) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-008-0153-3 · Cited by 11 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

The formulation of nanomedicines for treating tuberculosis

Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123 · see citing works

Application of liposomes as carriers of anti-tumor drugs

Wei-jin, C. (2009) · Zhongguo xin yao zazhi

Vesicular Phospholipid Gels

Brandl, M., & Massing, U. (2003) · doi:10.1093/oso/9780199636556.003.0014 · Cited by 7 · see citing works

Delivering more for less: nanosized, minimal-carrier and pharmacoactive drug delivery systems

Etter, E. L., Mei, K., & Nguyen, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113994 · Cited by 102 · see citing works

Liposomal sustained-release delivery systems for intravenous injection. II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes.

Tokunaga, Y., IWASA, T., Fujisaki, J., et al. (1988) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.36.3557 · Cited by 21 · see citing works

Liposomes: a drug carrier system for topical treatment in dermatology.

Schmid, M.-H., & Korting, H. C. (1994) · PubMed · Cited by 49 · see citing works